Literature DB >> 23464689

Surgical management of high-risk breast lesions.

Amy C Degnim1, Tari A King.   

Abstract

High-risk lesions of the breast are lesions that confer an increased risk of breast cancer, either because of an increased probability of finding cancer associated with percutaneous biopsy findings or because of an increased probability of developing breast cancer over the long term. Atypical ductal hyperplasia found on percutaneous biopsy is generally excised, whereas lobular neoplasia lesions, including both atypical lobular hyperplasia and lobular carcinoma in situ, may be observed if radiologic and pathologic findings are concordant and there is no other high-risk lesion present.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23464689     DOI: 10.1016/j.suc.2012.12.005

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  16 in total

1.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.

Authors:  K Pinker; W Bogner; P Baltzer; S Trattnig; S Gruber; O Abeyakoon; M Bernathova; O Zaric; P Dubsky; Z Bago-Horvath; M Weber; D Leithner; T H Helbich
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

Review 2.  Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.

Authors:  Savitri Krishnamurthy; Therese Bevers; Henry M Kuerer; Benjamin Smith; Wei Tse Yang
Journal:  AJR Am J Roentgenol       Date:  2016-12-08       Impact factor: 3.959

3.  Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer.

Authors:  Sima Ehsani; Roberta M Strigel; Erica Pettke; Lee Wilke; Amye J Tevaarwerk; Wendy B DeMartini; Kari B Wisinski
Journal:  Breast J       Date:  2015-03-17       Impact factor: 2.431

Review 4.  Current management of lesions associated with an increased risk of breast cancer.

Authors:  Monica Morrow; Stuart J Schnitt; Larry Norton
Journal:  Nat Rev Clin Oncol       Date:  2015-01-27       Impact factor: 66.675

5.  Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).

Authors:  Keiko Tsuchiya; Naoko Mori; David V Schacht; Deepa Sheth; Gregory S Karczmar; Gillian M Newstead; Hiroyuki Abe
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

Review 6.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

7.  Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma.

Authors:  Isabelle L Crary; Elizabeth U Parker; Kathryn P Lowry; Pranav P Patwardhan; Thing Rinda Soong; Sara H Javid; Kristine E Calhoun; Meghan R Flanagan
Journal:  Ann Surg Oncol       Date:  2022-07-08       Impact factor: 4.339

8.  ASO Author Reflections: Is Surgical Excision Necessary in Lobular Neoplasia with Synchronous Breast Carcinoma?

Authors:  Isabelle L Crary; Meghan R Flanagan
Journal:  Ann Surg Oncol       Date:  2022-07-11       Impact factor: 4.339

9.  High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.

Authors:  Eumee Cha; Emily B Ambinder; Eniola T Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Philip A Di Carlo; Kelly S Myers
Journal:  Breast Cancer Res Treat       Date:  2022-10-15       Impact factor: 4.624

10.  Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.

Authors:  Sunitha B Thakur; Joao V Horvat; Ileana Hancu; Olivia M Sutton; Blanca Bernard-Davila; Michael Weber; Jung Hun Oh; Maria Adele Marino; Daly Avendano; Doris Leithner; Sandra Brennan; Dilip Giri; Elizabeth Manderski; Elizabeth A Morris; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2019-01-03       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.